AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 FEB 22 - (NewsRx.com) -- by Michael Greer, staff medical writer -- Researchers in California believe that efforts to increase voluntary HIV screening of pregnant women both before and after delivery are cost-effective ways of preventing infection.
D.K. Owens and colleagues at Stanford University conducted a study to "evaluate the cost effectiveness of voluntary prenatal and routine postnatal HIV screening in the cohort of pregnant women and newborns in the United States," with the results published in the Journal of Acquired Immune Deficiency Syndromes.
Owens et al. developed a statistical model to quantify the expected results of enhanced HIV screening for pregnant women and newborns in terms of prevented infections and increased life expectancy ("The cost effectiveness of voluntary prenatal and routine newborn HIV screening in the United States," JAcq Immune Defic Syndr, 2000;25(5):403-416).
Efforts by health care workers to initiate routine and voluntary HIV screening for pregnant women would lead to an additional 1.1 million screenings every year, the researchers found. The benefit of these additional screenings would be the identification of 527 more HIV positive, soon-tobe mothers, Owens et al., calculated, and the prevention of 150 neonatal infections.
At an estimated cost of $8,900 for every year of life extended by enhanced screening programs, these programs are very cost-effective, with the conventional threshold level for cost-effectiveness being roughly $50,000 per life-year, the study ...
Source: HighBeam Research, Testing Pregnant Women is Cost-Effective.(voluntary HIV screening for...